CORC

在结果中检索

CORC

浏览/检索结果: 共62条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Sweroside ameliorated carbon tetrachloride (CCl4)-induced liver fibrosis through FXR-miR-29a signaling pathway. 期刊论文
Journal of natural medicines, 2019
作者:  Gong Junting;  Yang Fan;  Yang Qiaoling;  Tang Xiaowen;  Shu Fangfang
收藏  |  浏览/下载：69/0  |  提交时间：2019/12/05
Determination of BPI15086 and its metabolite in human plasma by ultra-high performance liquid chromatography-MS/MS and its application to a pharmacokinetic study 期刊论文
2019, 卷号: 11, 期号: 8, 页码: 773-784
作者:  Wang Shaoyuan;  Zheng Xin;  Zhang Yanbao;  Hu Pei;  Ding Lieming
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
An updated analysis of ICOGEN to demonstrate utility of a blood-based proteomic test to predict outcomes in EGFR TKI treated patients. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Li;  Ding, Lieming;  Dupuis, Nicholas
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04
An updated analysis of ICOGEN to demonstrate utility of a blood-based proteomic test to predict outcomes in EGFR TKI treated patients. 期刊论文
2017, 卷号: 35
作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Li;  Ding, Lieming;  Dupuis, Nicholas
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04
扶正化瘀方抗大鼠肝纤维化疗效的代谢组学研究 期刊论文
中成药, 2016, 卷号: 38, 期号: 11
作者:  仰贤莉;  李光伟;  康璐;  章弘扬;  徐列明
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
A retrospective analysis of the ICOGEN clinical trial demonstrates the utility of VeriStrat to predict outcome in an all Chinese cohort treated with EGFR TKI. 期刊论文
2016, 卷号: 34, 期号: 15
作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Li;  Ding, Lieming;  Dupuis, Nicholas
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04
First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE). 期刊论文
2016, 卷号: 34, 期号: 15
作者:  Shi, Yuankai;  Wang, Lin;  Han, Baohui;  Li, Wei;  Yu, Ping
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
A retrospective analysis of the ICOGEN clinical trial demonstrates the utility of VeriStrat to predict outcome in an all Chinese cohort treated with EGFR TKI. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Li;  Ding, Lieming;  Dupuis, Nicholas
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04
First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Shi, Yuankai;  Wang, Lin;  Han, Baohui;  Li, Wei;  Yu, Ping
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
First-Line Icotinib Versus Cisplatine/Pemetrexed Plus Pemetrexed Maintenance in Advanced NSCLC Patients with EGFR Mutation 会议论文
作者:  Ren, Xinling;  Shi, Yuankai;  Wang, Lin;  Han, Baohui;  Li, Wei
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace